During the past decade, Imaging Endpoints conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Imaging Endpoints" #1 sponsor was "Avid Radiopharmaceuticals" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Cognition Therapeutics" with 1 trials sponsored, "Navidea Biopharmaceuticals" with 1 trials sponsored and "T3D Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Imaging Endpoints" #1 collaborator was "Alzheimer's Association" with 1 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Imaging Endpoints" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (1 trials), "Cognition Disorders" (1 trials), "Mild to Moderate Alzheimer's Disease" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Imaging Endpoints" in a lesser frequency.

Most popular intervention types in "Imaging Endpoints" are "Drug" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "15mg T3D-959" (1 trials), "30 mg T3D-959" (1 trials), "45 mg T3D-959" (1 trials), "CT1812" (1 trials) and "Flortaucipir F18" (1 trials). Other intervention names were less common.

The vast majority of trials in "Imaging Endpoints" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Imaging Endpoints". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Imaging Endpoints, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Imaging Endpoints, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".